Now hearX Group sets new standard in hearing diagnostics with hearOAE NextGen OAE testing device

hearX Group has introduced its newest smartphone and tablet-based otoacoustic emissions hearing diagnostics (OAE) device, hearOAE. The company officially opened presales for the device after a successful preview at AAA+hearTECH expo in Atlanta in April.

An FDA-cleared medical device, hearOAE offers easy-to-use, fully customisable Transient Evoked OAE (TEOAE) and Distortion Product OAE (DPOAE) screening and diagnostic capabilities according to the company. The device also provides integrated data management.

“Rapid advances in hearing care technology has allowed us to make huge strides in how we detect, diagnose and treat hearing,” said Nic Klopper, hearX Group CEO. “Drawing from cutting-edge audiological science and mobile technology, the hearOAE is a powerful tool in the effort to address worldwide hearing loss.”

With its simple interface and powerful software, the hearOAE is designed to improve access to hearing care in areas where it is most needed, including newborn care, elder care, and in other situations where non-responsive testing and early intervention is critical.

It also integrates with hearX Group’s other detection and diagnostic products, including the popular mHealth Studio, designed to meet today’s healthcare demands with modern digital health tools. 

hearOAE is available for pre-order in the US and South Africa now, starting from 1,600 USD. Early adopters will secure exclusive savings and gain access to this groundbreaking technology.